These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21039823)

  • 1. Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1.
    Feldmann R; Schuierer G; Wessel A; Neveling N; Weglage J
    Acta Paediatr; 2010 Nov; 99(11):1657-60. PubMed ID: 21039823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
    Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
    Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities.
    Feldmann R; Denecke J; Grenzebach M; Schuierer G; Weglage J
    Neurology; 2003 Dec; 61(12):1725-8. PubMed ID: 14694037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.
    Hyman SL; Gill DS; Shores EA; Steinberg A; North KN
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1088-91. PubMed ID: 17299016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI and nonverbal cognitive deficits in children with neurofibromatosis 1.
    Bawden H; Dooley J; Buckley D; Camfield P; Gordon K; Riding M; Llewellyn G
    J Clin Exp Neuropsychol; 1996 Dec; 18(6):784-92. PubMed ID: 9157104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corpus callosum morphology and its relationship to cognitive function in neurofibromatosis type 1.
    Pride N; Payne JM; Webster R; Shores EA; Rae C; North KN
    J Child Neurol; 2010 Jul; 25(7):834-41. PubMed ID: 20142468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the frontal subcortical brain vulnerability hypothesis in children with neurofibromatosis type 1: Are T2-weighted hyperintensities related to executive dysfunction?
    Roy A; Barbarot S; Charbonnier V; Gayet-Delacroix M; Stalder JF; Roulin JL; Le Gall D
    Neuropsychology; 2015 May; 29(3):473-84. PubMed ID: 25365565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalamo-striatal T2-weighted hyperintensities (unidentified bright objects) correlate with cognitive impairments in neurofibromatosis type 1 during childhood.
    Chabernaud C; Sirinelli D; Barbier C; Cottier JP; Sembely C; Giraudeau B; Deseille-Turlotte G; Lorette G; Barthez MA; Castelnau P
    Dev Neuropsychol; 2009; 34(6):736-48. PubMed ID: 20183730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning.
    Piscitelli O; Digilio MC; Capolino R; Longo D; Di Ciommo V
    Dev Med Child Neurol; 2012 Jan; 54(1):49-51. PubMed ID: 22107256
    [No Abstract]   [Full Text] [Related]  

  • 10. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.
    Hyman SL; Gill DS; Shores EA; Steinberg A; Joy P; Gibikote SV; North KN
    Neurology; 2003 Apr; 60(7):1139-45. PubMed ID: 12682321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive control in adolescents with neurofibromatosis type 1.
    Rowbotham I; Pit-ten Cate IM; Sonuga-Barke EJ; Huijbregts SC
    Neuropsychology; 2009 Jan; 23(1):50-60. PubMed ID: 19210032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Encephalic lesions in neurofibromatosis: clinical manifestations and typical magnetic resonance findings].
    Magnaldi S; White RM; Bryan RN
    Radiol Med; 1990 Dec; 80(6):796-807. PubMed ID: 2126389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cognitive impairment in adults with neurofibromatosis type 1].
    Uttner I; Wahlländer-Danek U; Danek A
    Fortschr Neurol Psychiatr; 2003 Mar; 71(3):157-62. PubMed ID: 12624853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1.
    Hyman SL; Shores A; North KN
    Neurology; 2005 Oct; 65(7):1037-44. PubMed ID: 16217056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive profiles of neurofibromatosis type 1 patients with minor brain malformations.
    Acosta MT; Walsh KS; Kardel PG; Kutteruf RE; Bhatt RR; Bouton TC; Vezina LG; Packer RJ
    Pediatr Neurol; 2012 Apr; 46(4):231-4. PubMed ID: 22490768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal assessment of cognition and T2-hyperintensities in NF1: an 18-year study.
    Payne JM; Pickering T; Porter M; Oates EC; Walia N; Prelog K; North KN
    Am J Med Genet A; 2014 Mar; 164A(3):661-5. PubMed ID: 24357578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis.
    Moore BD; Slopis JM; Schomer D; Jackson EF; Levy BM
    Neurology; 1996 Jun; 46(6):1660-8. PubMed ID: 8649566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive profile of neurofibromatosis type 1.
    Levine TM; Materek A; Abel J; O'Donnell M; Cutting LE
    Semin Pediatr Neurol; 2006 Mar; 13(1):8-20. PubMed ID: 16818171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social functioning in adults with neurofibromatosis type 1.
    Pride NA; Crawford H; Payne JM; North KN
    Res Dev Disabil; 2013 Oct; 34(10):3393-9. PubMed ID: 23911645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.